- Home
- IFRX vs LXEH Comparison
IFRX vs LXEH Comparison
Compare IFRX & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- LXEH
- Stock Information
- Founded
- IFRX 2007
- LXEH 2001
- Country
- IFRX Germany
- LXEH China
- Employees
- IFRX N/A
- LXEH N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- LXEH Other Consumer Services
- Sector
- IFRX Health Care
- LXEH Real Estate
- Exchange
- IFRX Nasdaq
- LXEH Nasdaq
- Market Cap
- IFRX 53.5M
- LXEH 55.2M
- IPO Year
- IFRX 2017
- LXEH 2020
- Fundamental
- Price
- IFRX $0.83
- LXEH $1.78
- Analyst Decision
- IFRX Strong Buy
- LXEH
- Analyst Count
- IFRX 4
- LXEH 0
- Target Price
- IFRX $7.75
- LXEH N/A
- AVG Volume (30 Days)
- IFRX 198.5K
- LXEH 484.5K
- Earning Date
- IFRX 08-07-2025
- LXEH 09-15-2025
- Dividend Yield
- IFRX N/A
- LXEH N/A
- EPS Growth
- IFRX N/A
- LXEH N/A
- EPS
- IFRX N/A
- LXEH N/A
- Revenue
- IFRX $191,224.00
- LXEH $4,493,795.00
- Revenue This Year
- IFRX N/A
- LXEH N/A
- Revenue Next Year
- IFRX $1,276.37
- LXEH N/A
- P/E Ratio
- IFRX N/A
- LXEH N/A
- Revenue Growth
- IFRX 54.36
- LXEH N/A
- 52 Week Low
- IFRX $0.71
- LXEH $1.15
- 52 Week High
- IFRX $2.82
- LXEH $50.08
- Technical
- Relative Strength Index (RSI)
- IFRX 44.92
- LXEH 49.32
- Support Level
- IFRX $0.74
- LXEH $1.67
- Resistance Level
- IFRX $0.86
- LXEH $2.50
- Average True Range (ATR)
- IFRX 0.07
- LXEH 0.38
- MACD
- IFRX -0.00
- LXEH 0.03
- Stochastic Oscillator
- IFRX 44.02
- LXEH 36.00
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.